Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Vasoreactivity of isolated aortic rings from dyslipidemic and insulin resistant inducible nitric oxide synthase knockout mice.

Pathak P, Kanshana JS, Kanuri B, Rebello SC, Aggarwal H, Jagavelu K, Dikshit M.

Eur J Pharmacol. 2019 Jul 15;855:90-97. doi: 10.1016/j.ejphar.2019.05.005. Epub 2019 May 4.

PMID:
31063772
2.

Therapy With Biologic Agents After Diagnosis of Solid Malignancies: Results From the Corrona Registry.

Pappas DA, Rebello S, Liu M, Schenfeld J, Li Y, Collier DH, Accortt NA.

J Rheumatol. 2019 Apr 1. pii: jrheum.171457. doi: 10.3899/jrheum.171457. [Epub ahead of print]

3.

Conversion of food and kitchen waste to value-added products.

Sindhu R, Gnansounou E, Rebello S, Binod P, Varjani S, Thakur IS, Nair RB, Pandey A.

J Environ Manage. 2019 Jul 1;241:619-630. doi: 10.1016/j.jenvman.2019.02.053. Epub 2019 Mar 15. Review.

PMID:
30885564
4.

Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry.

Harrold LR, Litman HJ, Connolly SE, Alemao E, Kelly S, Rebello S, Hua W, Kremer JM.

Rheumatol Ther. 2019 Jun;6(2):217-230. doi: 10.1007/s40744-019-0149-3. Epub 2019 Mar 13.

5.

An 11-country study to benchmark the implementation of recommended nutrition policies by national governments using the Healthy Food Environment Policy Index, 2015-2018.

Vandevijvere S, Barquera S, Caceres G, Corvalan C, Karupaiah T, Kroker-Lobos MF, L'Abbé M, Ng SH, Phulkerd S, Ramirez-Zea M, Rebello SA, Reyes M, Sacks G, Sánchez Nóchez CM, Sanchez K, Sanders D, Spires M, Swart R, Tangcharoensathien V, Tay Z, Taylor A, Tolentino-Mayo L, Van Dam R, Vanderlee L, Watson F, Whitton C, Swinburn B.

Obes Rev. 2019 Jan 4. doi: 10.1111/obr.12819. [Epub ahead of print]

PMID:
30609260
6.

Non-conventional yeast cell factories for sustainable bioprocesses.

Rebello S, Abraham A, Madhavan A, Sindhu R, Binod P, Karthika Bahuleyan A, Aneesh EM, Pandey A.

FEMS Microbiol Lett. 2018 Nov 1;365(21). doi: 10.1093/femsle/fny222.

PMID:
30212856
7.

Impact of tax and subsidy framed messages on high- and lower-sugar beverages sold in vending machines: a randomized crossover trial.

Seah SSY, Rebello SA, Tai BC, Tay Z, Finkelstein EA, van Dam RM.

Int J Behav Nutr Phys Act. 2018 Aug 13;15(1):76. doi: 10.1186/s12966-018-0711-3.

8.

Relative validity and reproducibility of dietary quality scores from a short diet screener in a multi-ethnic Asian population.

Whitton C, Ho JCY, Rebello SA, van Dam RM.

Public Health Nutr. 2018 Oct;21(15):2735-2743. doi: 10.1017/S1368980018001830. Epub 2018 Aug 7.

PMID:
30081973
9.

Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry.

Alemao E, Litman HJ, Connolly SE, Kelly S, Hua W, Rosenblatt L, Rebello S, Kremer JM, Harrold LR.

J Rheumatol. 2018 Oct;45(10):1353-1360. doi: 10.3899/jrheum.171050. Epub 2018 Jul 1.

10.

Applications of Microbial Enzymes in Food Industry.

Raveendran S, Parameswaran B, Ummalyma SB, Abraham A, Mathew AK, Madhavan A, Rebello S, Pandey A.

Food Technol Biotechnol. 2018 Mar;56(1):16-30. doi: 10.17113/ftb.56.01.18.5491. Review.

11.
12.

Glucose and lipid metabolism alterations in liver and adipose tissue pre-dispose p47phox knockout mice to systemic insulin resistance.

Kanuri BN, Rebello SC, Pathak P, Agarwal H, Kanshana JS, Awasthi D, Gupta AP, Gayen JR, Jagavelu K, Dikshit M.

Free Radic Res. 2018 May;52(5):568-582. doi: 10.1080/10715762.2018.1453136. Epub 2018 Apr 3.

PMID:
29544378
13.

Hypericum japonicum: a Double-Headed Sword to Combat Vector Control and Cancer.

Puthur S, Anoopkumar AN, Rebello S, Aneesh EM.

Appl Biochem Biotechnol. 2018 Sep;186(1):1-11. doi: 10.1007/s12010-018-2713-7. Epub 2018 Feb 24.

PMID:
29476319
14.

Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study.

Larmore CJ, Boytsov NN, Gaich CL, Zhang X, Araujo AB, Rebello S, Salim BA, Reed GW, Harrold LR.

Rheumatol Ther. 2018 Jun;5(1):215-229. doi: 10.1007/s40744-017-0092-0. Epub 2018 Jan 10.

15.

Standardized fraction of Xylocarpus moluccensis fruits improve vascular relaxation and plaque stability in dyslipidemic models of atherosclerosis.

Kanshana JS, Rebello SC, Pathak P, Kanuri BN, Aggarwal H, Srivastava V, Khanna V, Singh V, Jagavelu K, Barthwal MK, Dikshit M.

J Ethnopharmacol. 2018 Mar 1;213:81-91. doi: 10.1016/j.jep.2017.11.004. Epub 2017 Nov 10.

PMID:
29129602
16.

Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin.

Gu H, Dutreix C, Rebello S, Ouatas T, Wang L, Chun DY, Einolf HJ, He H.

Drug Metab Dispos. 2018 Feb;46(2):109-121. doi: 10.1124/dmd.117.078006. Epub 2017 Nov 8.

PMID:
29117990
17.

Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study.

Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM.

J Rheumatol. 2018 Jan;45(1):32-39. doi: 10.3899/jrheum.170007. Epub 2017 Nov 1.

18.

A novel three-stage bioreactor for the effective detoxification of sodium dodecyl sulphate from wastewater.

Ambily PS, Rebello S, Jayachandran K, Jisha MS.

Water Sci Technol. 2017 Oct;76(7-8):2167-2176. doi: 10.2166/wst.2017.389.

PMID:
29068346
19.

Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity.

Harrold LR, Stolshek BS, Rebello S, Collier DH, Mutebi A, Wade SW, Malley W, Greenberg JD, Etzel CJ.

J Rheumatol. 2018 Jan;45(1):78-82. doi: 10.3899/jrheum.161567. Epub 2017 Oct 1.

PMID:
28966209
20.

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.

Accortt NA, Lesperance T, Liu M, Rebello S, Trivedi M, Li Y, Curtis JR.

Arthritis Care Res (Hoboken). 2018 May;70(5):679-684. doi: 10.1002/acr.23426. Epub 2018 Mar 11.

21.

Relative Validity and Reproducibility of a Food Frequency Questionnaire for Assessing Dietary Intakes in a Multi-Ethnic Asian Population Using 24-h Dietary Recalls and Biomarkers.

Whitton C, Ho JCY, Tay Z, Rebello SA, Lu Y, Ong CN, van Dam RM.

Nutrients. 2017 Sep 25;9(10). pii: E1059. doi: 10.3390/nu9101059.

22.

Determinants of eating at local and western fast-food venues in an urban Asian population: a mixed methods approach.

Naidoo N, van Dam RM, Ng S, Tan CS, Chen S, Lim JY, Chan MF, Chew L, Rebello SA.

Int J Behav Nutr Phys Act. 2017 May 25;14(1):69. doi: 10.1186/s12966-017-0515-x.

23.

Prevalence and descriptive epidemiology of atopic dermatitis and its impact on quality of life in Singapore.

Cheok S, Yee F, Song Ma JY, Leow R, Ho MSL, Yew YW, Tay YK, Rebello SA, Luo N, Koh MJA.

Br J Dermatol. 2018 Jan;178(1):276-277. doi: 10.1111/bjd.15587. Epub 2017 Oct 23. No abstract available.

PMID:
28415136
24.

Corrigendum: Altered glucose and lipid homeostasis in liver and adipose tissue pre-dispose inducible NOS knockout mice to insulin resistance.

Kanuri BN, Kanshana JS, Rebello SC, Pathak P, Gupta AP, Gayen JR, Jagavelu K, Dikshit M.

Sci Rep. 2017 Apr 6;7:46010. doi: 10.1038/srep46010. No abstract available.

25.

Biocontrol potential of Halotolerant bacterial chitinase from high yielding novel Bacillus Pumilus MCB-7 autochthonous to mangrove ecosystem.

Rishad KS, Rebello S, Shabanamol PS, Jisha MS.

Pestic Biochem Physiol. 2017 Apr;137:36-41. doi: 10.1016/j.pestbp.2016.09.005. Epub 2016 Sep 28.

PMID:
28364802
26.

Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.

Harrold LR, Stolshek BS, Rebello S, Collier DH, Mutebi A, Wade SW, Malley W, Greenberg JD, Etzel CJ.

Clin Rheumatol. 2017 Apr;36(4):895-901. doi: 10.1007/s10067-017-3593-x. Epub 2017 Mar 7.

PMID:
28271234
27.

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

Harrold LR, Litman HJ, Connolly SE, Kelly S, Hua W, Alemao E, Rosenblatt L, Rebello S, Kremer JM.

Clin Rheumatol. 2017 Jun;36(6):1215-1220. doi: 10.1007/s10067-017-3588-7. Epub 2017 Mar 1.

28.

Molecular advancements in the development of thermostable phytases.

Rebello S, Jose L, Sindhu R, Aneesh EM.

Appl Microbiol Biotechnol. 2017 Apr;101(7):2677-2689. doi: 10.1007/s00253-017-8195-7. Epub 2017 Feb 23. Review.

PMID:
28233043
29.

A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug-Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients.

Einolf HJ, Zhou J, Won C, Wang L, Rebello S.

Drug Metab Dispos. 2017 Apr;45(4):361-374. doi: 10.1124/dmd.116.073585. Epub 2017 Jan 25.

PMID:
28122787
30.

Altered glucose and lipid homeostasis in liver and adipose tissue pre-dispose inducible NOS knockout mice to insulin resistance.

Kanuri BN, Kanshana JS, Rebello SC, Pathak P, Gupta AP, Gayen JR, Jagavelu K, Dikshit M.

Sci Rep. 2017 Jan 20;7:41009. doi: 10.1038/srep41009. Erratum in: Sci Rep. 2017 Apr 06;7:46010.

31.

Development of a Semi-Quantitative Food Frequency Questionnaire to Assess the Dietary Intake of a Multi-Ethnic Urban Asian Population.

Neelakantan N, Whitton C, Seah S, Koh H, Rebello SA, Lim JY, Chen S, Chan MF, Chew L, van Dam RM.

Nutrients. 2016 Aug 27;8(9). pii: E528. doi: 10.3390/nu8090528.

32.

Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients.

Boytsov N, Harrold LR, Mason MA, Gaich CL, Zhang X, Larmore CJ, Rebello S, Araujo AB.

Curr Med Res Opin. 2016 Dec;32(12):1959-1967. Epub 2016 Aug 25.

PMID:
27558077
33.

A randomized placebo-controlled trial of the effect of coffee consumption on insulin sensitivity: Design and baseline characteristics of the Coffee for METabolic Health (COMETH) study.

Alperet DJ, Rebello SA, Khoo EY, Tay Z, Seah SS, Tai BC, Emady-Azar S, Chou CJ, Darimont C, van Dam RM.

Contemp Clin Trials Commun. 2016 Aug 2;4:105-117. doi: 10.1016/j.conctc.2016.06.013. eCollection 2016 Dec 15.

34.

Determinants of individuals' participation in integrated chronic disease screening in Singapore.

Venkataraman K, Wee HL, Ng SHX, Rebello S, Tai ES, Lee J, Tan CS.

J Epidemiol Community Health. 2016 Dec;70(12):1242-1250. doi: 10.1136/jech-2016-207404. Epub 2016 Jun 10.

PMID:
27288523
35.

Infant Feeding Practices in a Multi-Ethnic Asian Cohort: The GUSTO Study.

Toh JY, Yip G, Han WM, Fok D, Low YL, Lee YS, Rebello SA, Saw SM, Kwek K, Godfrey KM, Chong YS, Chong MF.

Nutrients. 2016 May 13;8(5). pii: E293. doi: 10.3390/nu8050293.

36.

An Exposure-Response Modeling Approach to Examine the Relationship Between Potency of CYP3A Inducer and Plasma 4β-Hydroxycholesterol in Healthy Subjects.

Jiang X, Dutreix C, Jarugula V, Rebello S, Won CS, Sun H.

Clin Pharmacol Drug Dev. 2017 Jan;6(1):19-26. doi: 10.1002/cpdd.267. Epub 2016 Jun 10.

PMID:
27138546
37.

Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure.

Mangold JB, Wu F, Rebello S.

Clin Pharmacol Drug Dev. 2016 Jul;5(4):245-9. doi: 10.1002/cpdd.265. No abstract available.

PMID:
27138133
38.

Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol.

Hsiao HL, Langenickel TH, Greeley M, Roberts J, Zhou W, Pal P, Rebello S, Rajman I, Sunkara G.

Clin Pharmacol Drug Dev. 2015 Nov;4(6):407-17. doi: 10.1002/cpdd.183. Epub 2015 May 6.

PMID:
27137712
39.

Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.

Gan L, Jiang X, Mendonza A, Swan T, Reynolds C, Nguyen J, Pal P, Neelakantham S, Dahlke M, Langenickel T, Rajman I, Akahori M, Zhou W, Rebello S, Sunkara G.

Clin Pharmacol Drug Dev. 2016 Jan;5(1):27-39. doi: 10.1002/cpdd.181. Epub 2015 Nov 4.

PMID:
27119576
40.

Bioconversion of sodium dodecyl sulphate to rhamnolipids by transformed Escherichia coli DH5α cells-a novel strategy for rhamnolipid synthesis.

Rebello S, Joseph BV, Joseph SV, Jose L, Mundayoor S, Jisha MS.

J Appl Microbiol. 2016 Mar;120(3):638-46. doi: 10.1111/jam.13032.

41.

Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid.

Mendonza A, Hanna I, Meyers D, Koo P, Neelakantham S, Zhu B, Majumdar T, Rebello S, Sunkara G, Chen J.

J Clin Pharmacol. 2016 Mar;56(3):355-64. doi: 10.1002/jcph.595. Epub 2015 Nov 2.

PMID:
26189431
42.

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor.

Gan L, Langenickel T, Petruck J, Kode K, Rajman I, Chandra P, Zhou W, Rebello S, Sunkara G.

J Clin Pharmacol. 2016 Jan;56(1):78-86. doi: 10.1002/jcph.571. Epub 2015 Aug 24.

PMID:
26073563
43.

Evaluation of food effect on the oral bioavailability of pradigastat, a diacylglycerol acyltransferase 1 inhibitor.

Ayalasomayajula SP, Meyers CD, Yu J, Kagan M, Matott R, Pal P, Majumdar T, Su Z, Crissey A, Rebello S, Sunkara G, Chen J.

Biopharm Drug Dispos. 2015 Oct;36(7):452-61. doi: 10.1002/bdd.1958. Epub 2015 Jun 5.

PMID:
25963481
44.

Development and characterization of a monoclonal antibody against the putative T cells of Labeo rohita.

Rebello SC, Rathore G, Punia P, Sood N.

Cytotechnology. 2016 May;68(3):469-80. doi: 10.1007/s10616-014-9800-6. Epub 2015 Mar 7.

45.

Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects.

Chen J, Bhansali S, Neelakantham S, Trusley C, Majumdar T, Rebello S, Sunkara G, Meyers C.

Int J Clin Pharmacol Ther. 2015 Apr;53(4):317-24. doi: 10.5414/CP202288.

PMID:
25740268
46.

Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.

Kulmatycki K, Hanna I, Meyers D, Salunke A, Movva A, Majumdar T, Natrillo A, Vapurcuyan A, Rebello S, Sunkara G, Chen J.

Int J Clin Pharmacol Ther. 2015 May;53(5):345-55. doi: 10.5414/CP202275.

PMID:
25740267
47.

Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects.

Ayalasomayajula S, Meyers D, Koo P, Salunke A, Majumdar T, Rebello S, Sunkara G, Chen J.

Eur J Clin Pharmacol. 2015 Apr;71(4):425-32. doi: 10.1007/s00228-015-1822-2. Epub 2015 Mar 1.

PMID:
25724644
48.

Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor.

Hirano M, Meyers D, Golla G, Pal P, Pinot P, Lin T, Majumdar T, Rebello S, Sunkara G, Chen J.

Clin Pharmacokinet. 2015 Jul;54(7):761-70. doi: 10.1007/s40262-015-0235-9.

PMID:
25633714
49.

Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor.

Mita S, Meyers D, Pal P, Lin T, Majumdar T, Rebello S, Sunkara G, Chen J.

Clin Pharmacokinet. 2015 Jul;54(7):751-60. doi: 10.1007/s40262-015-0234-x.

PMID:
25627776
50.

Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects.

Ménard J, Rigel DF, Watson C, Jeng AY, Fu F, Beil M, Liu J, Chen W, Hu CW, Leung-Chu J, LaSala D, Liang G, Rebello S, Zhang Y, Dole WP.

J Transl Med. 2014 Dec 10;12:340. doi: 10.1186/s12967-014-0340-9.

Supplemental Content

Loading ...
Support Center